Injectable Semaglutide has not been evaluated by the FDA, but side effects are expected to be similar to other Semaglutide-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)
Conversely, downregulation was observed in genes linked to mitochondrial function and antioxidant defense, including ASCL1, located near genetic loci of T2D risk (Elgamal et al., 2023)
You can take the medication with food or without food
What makes Zepbound unique is that it is not just a GLP-1 receptor agonist
Stimulating GLP-1 Production Through Diet Studies of the Mediterranean diet show that the combination of lean protein, healthy fats, and dietary fiber-rich foods stimulate high levels of GLP-1 after meals (compared to a high-fiber vegetarian diet) 6